Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2005 by University of British Columbia.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00120978
First received: July 11, 2005
Last updated: May 8, 2006
Last verified: April 2005